J&J late-stage data for Caplyta shows improved sexual functioning
Johnson & Johnson added commercial support for Caplyta with late-stage data showing improved sexual functioning among depression patients, J&J shares were roughly flat, slipping.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.